Literature DB >> 25754885

Cardiovascular risk assessment: a global perspective.

Dong Zhao1, Jing Liu1, Wuxiang Xie1, Yue Qi1.   

Abstract

An important strategy in primary prevention of cardiovascular diseases (CVD) is the early identification of high-risk individuals. Effective implementation of a strategy to identify these individuals in a clinical setting is reliant on the availability of appropriate CVD risk-assessment models and guideline recommendations. Several well-known models for CVD risk assessment have been developed and utilized in the USA and Europe, but might not be suitable for use in other regions or countries. Very few reports have discussed the development of risk-assessment models and recommendations from a global perspective. In this Review, we discuss why risk-assessment methods developed from studies in one geographical region or ethnic population might not be suitable for other regions or populations, and examine the availability and characteristics of predictive models in areas beyond the USA or Europe. In addition, we compare the differences in risk-assessment recommendations outlined in CVD clinical guidelines from developed and developing countries, and consider their potential effect on clinical practice. This overview of cardiovascular risk assessment from a global perspective can potentially guide low-to-middle-income countries in the development or validation of their own CVD risk-assessment models, and the formulation of recommendations in their own clinical guidelines according to local requirements.

Entities:  

Mesh:

Year:  2015        PMID: 25754885     DOI: 10.1038/nrcardio.2015.28

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  97 in total

Review 1.  Review of clinical practice guidelines for the management of LDL-related risk.

Authors:  Pamela B Morris; Christie M Ballantyne; Kim K Birtcher; Steven P Dunn; Elaine M Urbina
Journal:  J Am Coll Cardiol       Date:  2014-07-15       Impact factor: 24.094

2.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

Review 3.  Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

Authors:  Marie Therese Cooney; Alexandra L Dudina; Ian M Graham
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

Review 4.  Overview of risk prediction models in cardiovascular disease research.

Authors:  Jisheng Cui
Journal:  Ann Epidemiol       Date:  2009-07-22       Impact factor: 3.797

5.  Quantifying options for reducing coronary heart disease mortality by 2020.

Authors:  Mark D Huffman; Donald M Lloyd-Jones; Hongyan Ning; Darwin R Labarthe; Maria Guzman Castillo; Martin O'Flaherty; Earl S Ford; Simon Capewell
Journal:  Circulation       Date:  2013-05-09       Impact factor: 29.690

6.  Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.

Authors:  Lei Chen; Andrew M Tonkin; Lynelle Moon; Paul Mitchell; Annette Dobson; Graham Giles; Michael Hobbs; Patrick J Phillips; Jonathan E Shaw; David Simmons; Leon A Simons; Anthony P Fitzgerald; Guy De Backer; Dirk De Bacquer
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-10

7.  European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Eur Heart J       Date:  2012-05-03       Impact factor: 29.983

8.  The current status of primary prevention in coronary heart disease.

Authors:  Cornel Pater
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

9.  A coronary heart disease prediction model: the Korean Heart Study.

Authors:  Sun Ha Jee; Yangsoo Jang; Dong Joo Oh; Byung-Hee Oh; Sang Hoon Lee; Seong-Wook Park; Ki-Bae Seung; Yejin Mok; Keum Ji Jung; Heejin Kimm; Young Duk Yun; Soo Jin Baek; Duk Chul Lee; Sung Hee Choi; Moon Jong Kim; Jidong Sung; BeLong Cho; Eung Soo Kim; Byung-Yeon Yu; Tae-Yong Lee; Jong Sung Kim; Yong-Jin Lee; Jang-Kyun Oh; Sung Hi Kim; Jong-Ku Park; Sang Baek Koh; Sat Byul Park; Soon Young Lee; Cheol-In Yoo; Moon Chan Kim; Hong-Kyu Kim; Joo-Sung Park; Hyeon Chang Kim; Gyu Jang Lee; Mark Woodward
Journal:  BMJ Open       Date:  2014-05-21       Impact factor: 2.692

10.  Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.

Authors:  Earl S Ford; Umed A Ajani; Janet B Croft; Julia A Critchley; Darwin R Labarthe; Thomas E Kottke; Wayne H Giles; Simon Capewell
Journal:  N Engl J Med       Date:  2007-06-07       Impact factor: 91.245

View more
  32 in total

Review 1.  Neutrophils as regulators of cardiovascular inflammation.

Authors:  Carlos Silvestre-Roig; Quinte Braster; Almudena Ortega-Gomez; Oliver Soehnlein
Journal:  Nat Rev Cardiol       Date:  2020-01-29       Impact factor: 32.419

2.  PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region.

Authors:  Nizal Sarrafzadegan; Razieh Hassannejad; Hamid Reza Marateb; Mohammad Talaei; Masoumeh Sadeghi; Hamid Reza Roohafza; Farzad Masoudkabir; Shahram Oveisgharan; Marjan Mansourian; Mohammad Reza Mohebian; Miquel Angel Mañanas
Journal:  PLoS One       Date:  2017-12-19       Impact factor: 3.240

Review 3.  Cardiovascular risk in patients with rheumatoid arthritis.

Authors:  Kim Lauper; Cem Gabay
Journal:  Semin Immunopathol       Date:  2017-04-28       Impact factor: 9.623

4.  A Simple Model for Predicting 10-Year Cardiovascular Risk in Middle-Aged to Older Chinese: Guangzhou Biobank Cohort Study.

Authors:  Ying Yue Huang; Wen Bo Tian; Chao Qiang Jiang; Wei Sen Zhang; Feng Zhu; Ya Li Jin; Tai Hing Lam; Lin Xu; Kar Keung Cheng
Journal:  J Cardiovasc Transl Res       Date:  2021-08-16       Impact factor: 3.216

Review 5.  Epidemiology and aetiology of heart failure.

Authors:  Boback Ziaeian; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2016-03-03       Impact factor: 32.419

6.  Development and Validation of a Prognostic Model to Predict High-Risk Patients for Coronary Heart Disease in Snorers With Uncontrolled Hypertension.

Authors:  Meng-Hui Wang; Mulalibieke Heizhati; Nan-Fang Li; Xiao-Guang Yao; Qin Luo; Meng-Yue Lin; Jing Hong; Yue Ma; Run Wang; Le Sun; Ying-Li Ren; Na Yue
Journal:  Front Cardiovasc Med       Date:  2022-04-21

7.  Absolute cardiovascular risk scores and medication use in rural India: a cross-sectional study.

Authors:  Mulugeta Molla Birhanu; Roger G Evans; Ayse Zengin; Michaela Riddell; Kartik Kalyanram; Kamakshi Kartik; Oduru Suresh; Nihal Jacob Thomas; Velandai K Srikanth; Amanda G Thrift
Journal:  BMJ Open       Date:  2022-04-22       Impact factor: 3.006

8.  Hyperuricemia and clustering of cardiovascular risk factors in the Chinese adult population.

Authors:  Jie Wu; Ling Qiu; Xin-Qi Cheng; Tao Xu; Wei Wu; Xue-Jun Zeng; Yi-Cong Ye; Xiu-Zhi Guo; Qian Cheng; Qian Liu; Li Liu; Cheng-Li Xu; Guang-Jin Zhu
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

9.  Prediction of 8-year risk of cardiovascular diseases in Korean adult population.

Authors:  Sung Hyouk Choi; Seung Min Lee; Su Hwan Kim; Minseon Park; Hyung-Jin Yoon
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

10.  Prevalence of diabetes and hypertension and their interaction effects on cardio-cerebrovascular diseases: a cross-sectional study.

Authors:  Zhehui Wang; Tubao Yang; Hanlin Fu
Journal:  BMC Public Health       Date:  2021-06-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.